Table 1.
Transgender Medicare Beneficiaries | |||
---|---|---|---|
No. identified | No. validated | % validated | |
ICD-9 diagnosis codes 302.50, 302.51, 302.52, 302.53, 302.6, 302.85a | 4098 | 3658 | 89.26 |
Validation method | |||
ICD-9 302 series diagnosis code and 1 or more of the following: |
No. validated | % validated | |
---|---|---|
More than 1 claim with an ICD-9 302 series diagnosis code in 2013 | 2706 | 66.03 |
1 or more claims with an ICD-9 302 series diagnosis code in 2012 | 1577 | 38.48 |
1 or more claims with an ICD-9 302 series diagnosis code in 2014 | 1937 | 47.26 |
1 or more claims with an ICD-9 259.9 diagnosis code in 2013 | 568 | 13.86 |
1 or more prescriptions for a sex hormone in 2013 | 2005 | 48.89 |
Principal diagnosis code is from ICD-9 302 series | 1736 | 42.36 |
1 or more CC 45 modifier | 167 | 4.08 |
1 or more KX modifier | 26 | 0.6 |
Each validation step is calculated independently from all other validation steps, and “% validated” is calculated from the total number of transgender beneficiaries identified (N=4098).
Referred to as the 302 series for the purposes of this table.
ICD-9, International Classification of Diseases ninth edition.